Tuesday, July 07, 2020 3:14:16 PM
Agree, does not entirely make sense.
But that's 2020 for ya. I believe that when Revive is granted Phase 3, you will see movement. Until then, big money only have their eyes on this. As stated in this report, Revive is one to watch.
https://www.genengnews.com/covid-19-candidates/revive-therapeutics-bucillamine/
https://www.genengnews.com/category/covid-19-candidates/covid-19-keeping-an-eye-on/
But that's 2020 for ya. I believe that when Revive is granted Phase 3, you will see movement. Until then, big money only have their eyes on this. As stated in this report, Revive is one to watch.
https://www.genengnews.com/covid-19-candidates/revive-therapeutics-bucillamine/
https://www.genengnews.com/category/covid-19-candidates/covid-19-keeping-an-eye-on/
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
